June 2023 FDA Recall Losartan Potassium by Strides Pharma Inc.
D-0895-2023 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Strides Pharma Inc. on June 26, 2023 for the product Losartan Potassium. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0895-2023

Reason for Recall
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Initiated
06-26-2023
Reported
07-12-2023
Quantity
2,700 HDPE Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA.
Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08

Batch or Lot Expiration Information

Lot# : 7901903A, exp. date 04/2024